Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.
about
Site-specific gene expression patterns in oral cancer.Validity of the age-adjusted charlson comorbidity index on clinical outcomes for patients with nasopharyngeal cancer post radiation treatment: a 5-year nationwide cohort study.Adjuvant Radiation Therapy Alone for HPV Related Oropharyngeal Cancers with High Risk Features.Survival Outcomes and Patterns of Recurrence in Patients with Stage III or IV Oropharyngeal Cancer Treated with Primary Surgery or Radiotherapy.Prognostic Importance of Comorbidity and the Association Between Comorbidity and p16 in Oropharyngeal Squamous Cell Carcinoma.Role of comorbidity on outcome of head and neck cancer: a population-based study in Thuringia, Germany.A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer.Circulating and disseminated tumour cells in head and neck cancer.Development and validation of a new comorbidity index for patients with head and neck squamous cell carcinoma in JapanOropharyngeal cancer and human papilloma virus: evolving diagnostic and management paradigms.A stratified analysis of the perioperative outcome of 17623 patients undergoing major head and neck cancer surgery in England over 10 years: Towards an Informatics-based Outcomes Surveillance Framework.Prognostic value of comorbidities in patients with carcinoma of the major salivary glands.The Charlson comorbidity index is a prognostic factor in sinonasal tract squamous cell carcinoma.Cardiac comorbidity in head and neck cancer patients and its influence on cancer treatment selection and mortality: a prospective cohort study.Age-adjusted Charlson Comorbidity Index predicts prognosis of laryngopharyngeal cancer treated with radiation therapy.Radiosensitization by CpG ODN7909 in an epidermoid laryngeal carcinoma Hep-2 cell line.
P2860
Q33655260-FE30F2D5-7C13-459E-98A5-C6B7958BCA42Q35008974-4F112DB7-9536-4503-9737-B40CA1959C0BQ36216266-1923D320-2A5B-4530-8A29-33B8B89D1F0DQ37214324-90A17592-45B5-43BD-B13F-A510777E77A2Q37376041-55785EA5-5415-4838-BC42-6C32CF79CDE4Q37429990-D542DDB4-0809-4A1E-9BFD-2211B70A120CQ38418103-95DE6CC2-C0D9-4AD2-B2A7-0D61019062BEQ38547000-1661A304-D541-454D-8CAB-45256BC0AB3DQ38639725-55A6D9EB-F677-4FB5-8029-5CC3542B084BQ38674531-64A0D352-EBEC-432C-9A7F-98CD5B55E7C6Q39909441-984A81A7-B998-4C55-B051-61469F648C80Q40456822-8D502BA7-9B0B-4C0F-A8FD-5E60D04D4387Q40762249-36DDC179-1F63-40D2-A4DA-DEAE686E1D6CQ41115330-2D38BDC5-41B9-4E70-B750-8E48F71BD052Q48122486-2651CE75-8B4D-44C4-9EEC-162AF4239514Q49799180-638F225E-0ACD-4F18-B42A-6407C77E6127
P2860
Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Comorbidity and prognosis in h ...... d human papillomavirus status.
@en
Comorbidity and prognosis in h ...... d human papillomavirus status.
@nl
type
label
Comorbidity and prognosis in h ...... d human papillomavirus status.
@en
Comorbidity and prognosis in h ...... d human papillomavirus status.
@nl
prefLabel
Comorbidity and prognosis in h ...... d human papillomavirus status.
@en
Comorbidity and prognosis in h ...... d human papillomavirus status.
@nl
P2093
P2860
P50
P356
P1433
P1476
Comorbidity and prognosis in h ...... d human papillomavirus status.
@en
P2093
Anthony La Delfa
David Goldstein
Ehab Fadhel
Luke T G Harland
Shao-Hui Huang
Steven Habbous
P2860
P304
P356
10.1002/HED.23360
P577
2013-07-30T00:00:00Z